The Becoming of Children With Doose Syndrome

Last updated: April 11, 2023
Sponsor: Centre Hospitalier Universitaire, Amiens
Overall Status: Active - Recruiting

Phase

N/A

Condition

Epilepsy

Unverricht-lundborg Syndrome

Williams Syndrome

Treatment

N/A

Clinical Study ID

NCT04048213
PI2018_843_0058
  • Ages 1-6
  • All Genders

Study Summary

Doose syndrome is a rare epileptic syndrome that can lead to learning difficulties and a poor quality of life. The goal of this study is to evaluate the evolution of epilepsy and its consequences on cognitive development and learning issues in children with Doose syndrome.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • children with doose syndrome diagnosed between ages 1 and 6
  • normal development until onset of seizures

Exclusion

Exclusion Criteria:

  • unconfirmed diagnoses
  • abnormal diagnoses
  • abnormal psychomotor development before onset of seizures
  • cerebral MRI abnormalities
  • other child epileptic syndromes

Study Design

Total Participants: 50
Study Start date:
August 01, 2019
Estimated Completion Date:
December 31, 2023

Study Description

Doose syndrome is a rare epileptic syndrome beginning between ages two and five, characterized by myoclonic-astatic seizures which can be associated with myoclonic seizures, astatic seizures, absences and generalized tonic-clonic seizures. These seizures can be difficult to treat effectively and may lead to learning difficulties. During this study, parents of children with Doose syndrome will receive a questionnaire regarding learning disabilities, quality of life and epilepsy of their children.

Connect with a study center

  • CHU Amiens

    Amiens, 80480
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.